SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

JPMorgan: Israel’s economic outlook hinges on length of Iran war

Insider links surface in Ondas’ Indo acquisition

Full list of Israeli high-tech funding rounds in 2026

Oasis Security raises $120 million Series B to secure the rise of AI agents

Buzz

Most popular

Daily

Weekly

1

Israel orders airborne laser system for fighter jets and helicopters

2

AWS veterans raise $31 million Series A for cyber startup Native to simplify multi-cloud security

3

Israeli startup Thermagix claims “the only economical solution for harvesting low-grade heat”

4

Palo Alto founder Nir Zuk sells digital bank Esh to Isracard at $130 million valuation

5

Niv-AI raises $12 million Seed round to unlock stranded power in data centers

Tourette Syndrome

1 stories about Tourette Syndrome

An Israeli Company Wants to Treat Tourette Syndrome With Cannabis

09.04.18|Lilach Baumer

Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday